News
AstraZeneca announced that it has entered into a licensing agreement with Ironwood Pharmaceuticals for the exclusive US rights to Zurampic®...
Read moreBristol-Myers Squibb Company announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Opdivo...
Read moreAstraZeneca and its global biologics research and development arm, MedImmune announced an integrated genomics initiative to transform drug discovery and...
Read more
LEO Pharma, a global healthcare company dedicated to helping people achieve healthy skin, announces Svend Andersen as incoming EVP, Head...
Read more
Will Represent Sixth U.S. Patent to Be Listed in the Orange Book for RAVICTI Horizon Pharma plc (NASDAQ: HZNP), a...
Read more
Takeda Licenses Global Rights to Outpost for Novel Clinical Stage Compound for the Potential Treatment of Stress Urinary Incontinence Frazier...
Read more
Alcon’s limited unilateral pricing policy applies only to new and innovative brands of contact lens and was introduced to encourage...
Read moreAbbVie and Boehringer Ingelheim announced a global collaboration to develop and commercialize BI 655066, an anti-IL-23 monoclonal biologic antibody in...
Read moreBioPh China 2016, hosted by UBM EMEA and China Chamber of Commerce of Medicines & Health Products Importers & Exporters...
Read moreThe P-Logi 2016, hosted by UBM Live and China Chamber of Commerce of Medicines & Health Products Importers & Exporters...
Read more
About Us
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.